Dr. Stacy N. Davis is a behavioral scientist with a broad background in public health and behavioral oncology. Her program of research is focused on addressing cancer disparities across the cancer control continuum. Dr. Davis uses community-based participatory research (CBPR) methods, the Multilevel Context of Cancer Care framework, and community-academic partnerships to: 1) promote informed decision making and early detection for prostate and colorectal cancer; 2) improve quality of life during and after cancer treatment; and 3) explore the role of novel communication interventions, such as mobile health (mHealth) technology, in adherence to evidence-based cancer recommendations.
Dr. Davis received Bachelor of Arts (BA) in Biological Sciences from the University of Delaware and a Master of Public Health (MPH) from Rutgers School of Public Health. She then earned a Doctor of Philosophy (PhD) in Public Health, with a concentration in Social and Behavioral Health Sciences from the College of Public Health at Temple University and completed a postdoctoral fellowship in Behavioral Oncology, within the Division of Health Outcomes and Behavior at Moffitt Cancer Center.
Dr. Davis’ recent work has focused on identifying the sociocultural, behavioral, and environmental determinants of cancer health disparities and translating this information into culturally-targeted, linguistically and literacy relevant interventions to improve cancer equity among underserved patients. As a result, Dr. Davis is Principal Investigator of a federally funded research study to explore the efficacy of a theory-based educational mHealth intervention to promote repeat colorectal cancer screening with a fecal immunochemical test (FIT) in patients who seek care in federally qualified health centers. Dr. Davis was also awarded a Diversity Supplement award from the National Cancer Institute (NCI) to examine whether health literacy and technology ownership and usage are associated with cancer surveillance and follow-up care among cancer survivors. Additionally, she has received pilot funding to conduct research to elicit physicians’ perspectives on barriers to and facilitators of lung cancer screening with low dose computed tomography (LDCT) among patients in New Jersey, particularly those are underserved.
Click below to make an appointment. We will follow up to confirm your reservation.
Make an Appointment
